Publications by authors named "Lisa Tushla"
Introduction: Invasive fungal disease (IFD) is a morbid superinfection that can arise in critically ill patients with COVID-19 infection. Studies evaluating the full spectrum of COVID-19-associated fungal infections remain limited.
Methods: Single-center retrospective study assessing IFD in patients with COVID-19, hospitalized for ≥ 72 h in the intensive care unit (ICU) between 02/25/20 and 02/28/22 (n = 1410).
Background: Recently, increasing focus on patient input into research and healthcare improvements has fostered expanded patient-centered advocacy efforts. This first pan-fungal disease summit, part of the MYCology Advocacy, Research, & Education effort, brought together patients, caregivers, and mycology experts to better document patient experiences with invasive fungal disease (IFD) and establish priorities for mycology education, advocacy, and research.
Methods: Patients who had suffered from IFD, their caregivers, clinicians, industry representatives, government officials, and patient advocacy professionals were invited.
Coccidioidomycosis, histoplasmosis, and blastomycosis are underrecognized and frequently misdiagnosed fungal infections that can clinically resemble bacterial and viral community-acquired pneumonia. This guidance is intended to help outpatient clinicians test for these fungal diseases in patients with community-acquired pneumonia to reduce misdiagnoses, unnecessary antibacterial use, and poor outcomes.
View Article and Find Full Text PDFArticle Synopsis
- - In March 2020, COVID-19 was declared a pandemic, and patients with severe cases are at risk for a dangerous fungal infection called pulmonary aspergillosis, which requires early detection to improve survival rates.
- - A team of 18 experts created an evidence-based Care Step Pathway tool to assist ICU clinicians in assessing and treating this infection in COVID-19 patients vaccinated with intensive support.
- - The tool proved effective in a real case, successfully aiding in the treatment of a patient suffering from COVID-19-associated aspergillosis, highlighting its importance in critical settings where traditional antibiotics fail.